Point72 Asset Management, L.P. 13D and 13G filings for Sagimet Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:55 pm Purchase | 2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT | Point72 Asset Management, L.P. | 2,468,128 8.000% | 855,489 (+53.05%) | Filing |
| 2024-02-05 4:34 pm Purchase | 2024-02-02 | 13G | Sagimet Biosciences Inc. SGMT | Point72 Asset Management, L.P. | 1,612,639 5.300% | 1,612,639 (New Position) | Filing |